Smeesters, PR, McMillan, DJ, Sriprakash, KS. The streptococcal M protein: a highly versatile molecule. Trends in Microbiology
2010; 18: 275–282.
Ghosh, P. The nonideal coiled coil of M protein and its multifarious functions in pathogenesis. Advances in Experimental Medicine and Biology
2011; 715: 197–211.
McMillan, DJ, et al.
Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clinical Microbiology and Infection
2013; 19: E222–229.
Muller-Eberhard, HJ. The membrane attack complex of complement. Annual Review of Immunology
1986; 4: 503–528.
Hoe, NP, et al.
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nature Medicine
1999; 5: 924–929.
Hoge, CW, et al.
The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. Journal of the American Medical Association
1993; 269: 384–389.
Stevens, DL. Invasive group A streptococcus infections. Clinical Infectious Diseases
1992; 14: 2–13.
Martin, J, et al.
Invasive Group A streptococcal disease in Ireland, 2004 to 2010. Eurosurveillance
2011; 16: 19988.
Meehan, M, et al.
Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013. Eurosurveillance
2013; 18: 20556.
Steer, AC, et al.
Invasive group A streptococcal disease: epidemiology, pathogenesis and management. Drugs
2012; 72: 1213–1227.
Ikebe, T, et al.
Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan. Japanese Journal of Infectious Diseases
2010; 63: 304–305.
Breiman, RF, et al.
Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. Journal of the American Medical Association
1993; 269: 390–391.
Beall, B, Facklam, R, Thompson, T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. Journal of Clinical Microbiology
1996; 34: 953–958.
Mejia, LM, et al.
Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein. Journal of Clinical Microbiology
1997; 35: 3220–3224.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. M100–S23, 2013. CLSI, Wayne, PA.
Richter, SS, et al.
Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clinical Infectious Diseases
2005; 41: 599–608.
De Azavedo, JCS, et al.
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrobial Agents and Chemotherapy
1999; 43: 2144–2147.
Sutcliffe, J, et al.
Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy
1996; 40: 2562–2566.
Ikebe, T, et al.
Surveillance of severe invasive group G streptococcal infections during 2002–2008 in Japan. Japanese Journal of Infectious Diseases
2010; 63: 372–375.
Eriksson, BK, et al.
Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clinical Infectious Diseases
1998; 27: 1428–1436.
Patel, RA, Binns, HJ, Shulman, ST. Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. Journal of Pediatrics
2004; 144: 68–74.
Dale, JB, et al.
Group A streptococcal vaccines: paving a path for accelerated development. Vaccine
2013; 31 (Suppl. 2): B216–222.
Bingen, E, et al.
Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrobial Agents in Chemotherapy
2004; 48: 3559–3562.
Montes, M, et al.
Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998–2009): comparison with non-invasive isolates. European Journal of Clinical Microbiology & Infectious Diseases
2011; 30: 1295–1302.
Liang, Y, et al.
Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. Journal of Medical Microbiology
2012; 61: 975–983.
Miyamoto, Y, et al.
Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type. Antimicrobial Agents and Chemotherapy
1978; 13: 399–404.
Hoe, NP, et al.
Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. Journal of Infectious Diseases
2001; 183: 633–639.